I think that the cash balance will be much lower than $54m, but the $2m EBIT forecast for 16/17 will also prove too low.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025